Trademark Overview
On Monday, November 11, 2024, a trademark application was filed for TOXNET with the United States Patent and Trademark Office. The USPTO has given the TOXNET trademark a serial number of 79420188. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 27, 2025. This trademark is owned by Merz Pharma GmbH & Co. KGaA. The TOXNET trademark is filed in the Advertising, Business and Retail Services, Paper & Printed Material Products, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:
Education services relating to pharmacy; medical education services; training services for medical visitors; conducting of instructional seminars; providing continuing medical education courses; arranging and conducting of workshops [training]; arranging and conducting of colloquiums; seminars; arranging of lectures; arranging and conducting of seminars; arranging and conducting of conventions; arranging and conducting of congresses; organization of seminars and conventions in the field of medicine; providing electronic publications; publication of printed matter; publishing of medical publications; on-line publishing services; online publication of electronic books and journals; publishing services; publication and editing of books; publication and editing of printed matter; publication of magazines.
Regulary printed publications; magazines, newspapers, printed instructional and teaching material; paper and stationery and instructional and teaching material; printed books, magazines, newspaper and other media in paper form; instructional and teaching material.
Advertisement services for goods and services via websites [online]; online advertising; advertisement via internet; advertising and publicity; advertisement including online-advertisement via a computer network; advertisement; marketing and sales promotion.
Medical research; pharmaceutical research and development; laboratory research services relating to pharmaceuticals; scientific research and development; research and development for the pharmaceutical industry; provision of research services; technological services; scientific services.
